Brigham & Women's Hospital Inc. was awarded a $830,409 Project Grant (R01MH136160) from the National Institute of Mental Health (CFDA 93.242 Mental Health Research Grants) to develop innovative software and computational techniques that integrate real-time navigated electric-field mapping and source-space electroencephalogram (EEG) analysis during transcranial magnetic stimulation (TMS) treatment. The project aims to significantly improve the accuracy of TMS targeting and dosimetry for individualized patients to enhance the efficacy of TMS treatment for brain diseases such as major depressive disorder, obsessive-compulsive disorder, and migraine. The award period runs from Mar 1, 2025 through Jan 31, 2030. As the prime awardee, Brigham & Women's Hospital will leverage its expertise in neurology, neuroimaging, and clinical research to achieve the project's goals.
Generated 3/18/25, 3:04 AM